To validate a possible association of RAI2 gene expression with altered DNA repair capacity in clinical samples, we calculated the recombination proficiency score (RPS), which predicts DNA DSB repair efficiency and sensitivity to DNA-damaging chemotherapy in breast cancer [34], for all TCGA samples and correlated the RPS score with RAI2 gene expression. The gene discussed is RAI2; the disease is breast carcinoma.